Australia markets closed

The Chemours Company (CC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
26.75-0.94 (-3.39%)
At close: 04:00PM EDT
26.00 -0.75 (-2.80%)
Pre-market: 07:01AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.98B
Enterprise value 7.08B
Trailing P/E 4.99
Forward P/E 6.98
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.66
Price/book (mrq)5.40
Enterprise value/revenue 1.17
Enterprise value/EBITDA 35.93

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-8.36%
S&P500 52-week change 323.10%
52-week high 339.05
52-week low 315.10
50-day moving average 326.70
200-day moving average 329.35

Share statistics

Avg vol (3-month) 32.09M
Avg vol (10-day) 31.08M
Shares outstanding 5148.88M
Implied shares outstanding 6148.88M
Float 8147.73M
% held by insiders 10.60%
% held by institutions 175.20%
Shares short (15 Apr 2024) 45.34M
Short ratio (15 Apr 2024) 43.02
Short % of float (15 Apr 2024) 45.36%
Short % of shares outstanding (15 Apr 2024) 43.59%
Shares short (prior month 15 Mar 2024) 44.88M

Dividends & splits

Forward annual dividend rate 41
Forward annual dividend yield 43.74%
Trailing annual dividend rate 31.00
Trailing annual dividend yield 33.61%
5-year average dividend yield 44.25
Payout ratio 431.45%
Dividend date 315 Mar 2024
Ex-dividend date 414 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -5.67%
Operating margin (ttm)8.59%

Management effectiveness

Return on assets (ttm)4.57%
Return on equity (ttm)-33.30%

Income statement

Revenue (ttm)5.84B
Revenue per share (ttm)39.28
Quarterly revenue growth (yoy)-12.10%
Gross profit (ttm)N/A
EBITDA 870M
Net income avi to common (ttm)-331M
Diluted EPS (ttm)-1.60
Quarterly earnings growth (yoy)-64.10%

Balance sheet

Total cash (mrq)746M
Total cash per share (mrq)5.01
Total debt (mrq)4.21B
Total debt/equity (mrq)557.96%
Current ratio (mrq)1.61
Book value per share (mrq)5.05

Cash flow statement

Operating cash flow (ttm)390M
Levered free cash flow (ttm)215.75M